241 related articles for article (PubMed ID: 24350582)
21. Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever.
Page-Sharp M; Coward J; Moore BR; Salman S; Marshall L; Davis TME; Batty KT; Manning L
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559267
[TBL] [Abstract][Full Text] [Related]
22. Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?
de Dassel JL; Ralph AP; Carapetis JR
Curr Opin Pediatr; 2015 Feb; 27(1):116-23. PubMed ID: 25490689
[TBL] [Abstract][Full Text] [Related]
23. Acute rheumatic fever and rheumatic heart disease--priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011.
Rémond MG; Wheaton GR; Walsh WF; Prior DL; Maguire GP
Heart Lung Circ; 2012 Oct; 21(10):632-8. PubMed ID: 22726405
[TBL] [Abstract][Full Text] [Related]
24. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.
Ralph AP; Noonan S; Wade V; Currie BJ
Med J Aust; 2021 Mar; 214(5):220-227. PubMed ID: 33190309
[TBL] [Abstract][Full Text] [Related]
25. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.
Kevat PM; Gunnarsson R; Reeves BM; Ruben AR
J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191
[TBL] [Abstract][Full Text] [Related]
26. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.
Rémond MG; Coyle ME; Mills JE; Maguire GP
Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106
[TBL] [Abstract][Full Text] [Related]
27. A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia.
Kerrigan V; Kelly A; Lee AM; Mungatopi V; Mitchell AG; Wyber R; Ralph AP
BMC Health Serv Res; 2021 Oct; 21(1):1127. PubMed ID: 34670567
[TBL] [Abstract][Full Text] [Related]
28. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010.
Lawrence JG; Carapetis JR; Griffiths K; Edwards K; Condon JR
Circulation; 2013 Jul; 128(5):492-501. PubMed ID: 23794730
[TBL] [Abstract][Full Text] [Related]
29. Qualitative Evaluation of a Complex Intervention to Improve Rheumatic Heart Disease Secondary Prophylaxis.
Read C; Mitchell AG; de Dassel JL; Scrine C; Hendrickx D; Bailie RS; Johnston V; Maguire GP; Schultz R; Carapetis JR; Ralph AP
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018166
[TBL] [Abstract][Full Text] [Related]
30. A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.
Hand RM; Salman S; Newall N; Vine J; Page-Sharp M; Bowen AC; Gray K; Baker A; Kado J; Joseph J; Marsh J; Ramsay J; Sika-Paotonu D; Batty KT; Manning L; Carapetis J
J Antimicrob Chemother; 2019 Jul; 74(7):1984-1991. PubMed ID: 30989171
[TBL] [Abstract][Full Text] [Related]
31. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué.
Watkins D; Zuhlke L; Engel M; Daniels R; Francis V; Shaboodien G; Kango M; Abul-Fadl A; Adeoye A; Ali S; Al-Kebsi M; Bode-Thomas F; Bukhman G; Damasceno A; Goshu DY; Elghamrawy A; Gitura B; Haileamlak A; Hailu A; Hugo-Hamman C; Justus S; Karthikeyan G; Kennedy N; Lwabi P; Mamo Y; Mntla P; Sutton C; Mocumbi AO; Mondo C; Mtaja A; Musuku J; Mucumbitsi J; Murango L; Nel G; Ogendo S; Ogola E; Ojji D; Olunuga TO; Redi MM; Rusingiza KE; Sani M; Sheta S; Shongwe S; van Dam J; Gamra H; Carapetis J; Lennon D; Mayosi BM
Cardiovasc J Afr; 2016 May/Jun 23; 27(3):184-187. PubMed ID: 26815006
[TBL] [Abstract][Full Text] [Related]
32. Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.
Barr RK; Barber BW; Tait JR; Landersdorfer CB; Salman S; Musk GC; Page-Sharp M; Batty KT; Kado J; Manning L; Carapetis JR; Boyd BJ
Eur J Pharm Biopharm; 2023 Aug; 189():240-250. PubMed ID: 37354997
[TBL] [Abstract][Full Text] [Related]
33. Patient preferences for prophylactic regimens requiring regular injections in children and adolescents: a systematic review and thematic analysis.
Ilievski J; Mirams O; Trowman R; Barr RK; Manning L
BMJ Paediatr Open; 2024 May; 8(1):. PubMed ID: 38769047
[TBL] [Abstract][Full Text] [Related]
34. Clonidine for pain-related distress in Aboriginal children on a penicillin regimen to prevent recurrence of rheumatic fever.
Mitchell A; Kelly J; Cook J; Atkinson N; Spain B; Remenyi B; Wade V; Ralph AP
Rural Remote Health; 2020 Nov; 20(4):5930. PubMed ID: 33147979
[TBL] [Abstract][Full Text] [Related]
35. The evidence that rheumatic heart disease control programs in Australia are making an impact.
Stacey I; Ralph A; de Dassel J; Nedkoff L; Wade V; Francia C; Wyber R; Murray K; Hung J; Katzenellenbogen J
Aust N Z J Public Health; 2023 Aug; 47(4):100071. PubMed ID: 37364309
[TBL] [Abstract][Full Text] [Related]
36. Rheumatic fever in indigenous Australian children.
Parnaby MG; Carapetis JR
J Paediatr Child Health; 2010 Sep; 46(9):527-33. PubMed ID: 20854325
[TBL] [Abstract][Full Text] [Related]
37. Rheumatic heart disease in indigenous populations--New Zealand experience.
Wilson N
Heart Lung Circ; 2010; 19(5-6):282-8. PubMed ID: 20395173
[TBL] [Abstract][Full Text] [Related]
38. A cluster of acute rheumatic fever cases among Aboriginal Australians in a remote community with high baseline incidence.
Francis JR; Gargan C; Remenyi B; Ralph AP; Draper A; Holt D; Krause V; Hardie K
Aust N Z J Public Health; 2019 Jun; 43(3):288-293. PubMed ID: 30994967
[TBL] [Abstract][Full Text] [Related]
39. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia.
Rémond MG; Severin KL; Hodder Y; Martin J; Nelson C; Atkinson D; Maguire GP
Intern Med J; 2013 Apr; 43(4):386-93. PubMed ID: 22646671
[TBL] [Abstract][Full Text] [Related]
40. How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.
de Dassel JL; de Klerk N; Carapetis JR; Ralph AP
J Am Heart Assoc; 2018 Dec; 7(24):e010223. PubMed ID: 30561268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
